 | • レポートコード：B-GIR08C0053 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、急性片頭痛薬の世界市場について調べ、まとめました。種類別セグメントは、非ステロイド性抗炎症薬、トリプタン、ジヒドロエルゴタミン、非特異的片頭痛薬、鎮痛薬等、用途別セグメントは、病院薬局、ドラッグストア、小売薬局、オンライン薬局等に区分しました。急性片頭痛薬の世界市場概観、企業動向、企業別急性片頭痛薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・急性片頭痛薬の市場概観 ・急性片頭痛薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・急性片頭痛薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・急性片頭痛薬の世界市場規模 ・急性片頭痛薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・急性片頭痛薬のアメリカ市場規模推移 ・急性片頭痛薬のカナダ市場規模推移 ・急性片頭痛薬のメキシコ市場規模推移 ・急性片頭痛薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・急性片頭痛薬のドイツ市場規模推移 ・急性片頭痛薬のイギリス市場規模推移 ・急性片頭痛薬のロシア市場規模推移 ・急性片頭痛薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・急性片頭痛薬の日本市場規模推移 ・急性片頭痛薬の中国市場規模推移 ・急性片頭痛薬の韓国市場規模推移 ・急性片頭痛薬のインド市場規模推移 ・急性片頭痛薬の東南アジア市場規模推移 ・急性片頭痛薬の南米市場分析（ブラジル、アルゼンチン等） ・急性片頭痛薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・急性片頭痛薬の種類別分析/販売量、売上、市場シェア（非ステロイド性抗炎症薬、トリプタン、ジヒドロエルゴタミン、非特異的片頭痛薬、鎮痛薬） ・急性片頭痛薬の用途別分析/市場規模（病院薬局、ドラッグストア、小売薬局、オンライン薬局） ・急性片頭痛薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・急性片頭痛薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Acute medications fall into general classes of medicines including analgesics, ergotamines and triptans.
Scope of the Report:
The worldwide market for Acute Migraine Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Acute Migraine Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Pfizer
Novartis
Eli Lily
AstraZeneca
Teva Pharmaceutical
Allergan
Abbott
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nonsteroidal Anti-Inflammatory Drugs
Triptans
Dihydroergotamine
Nonspecific Migraine Medications
Analgesics
Market Segment by Applications, can be divided into
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acute Migraine Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Acute Migraine Drugs, with price, sales, revenue and global market share of Acute Migraine Drugs in 2017 and 2018.
Chapter 3, the Acute Migraine Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acute Migraine Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Acute Migraine Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Acute Migraine Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Acute Migraine Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Nonsteroidal Anti-Inflammatory Drugs
1.2.2 Triptans
1.2.3 Dihydroergotamine
1.2.4 Nonspecific Migraine Medications
1.2.5 Analgesics
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Drug Stores
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Acute Migraine Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Acute Migraine Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Acute Migraine Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eli Lily
2.4.1 Business Overview
2.4.2 Acute Migraine Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lily Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Acute Migraine Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Teva Pharmaceutical
2.6.1 Business Overview
2.6.2 Acute Migraine Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceutical Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Allergan
2.7.1 Business Overview
2.7.2 Acute Migraine Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Allergan Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Abbott
2.8.1 Business Overview
2.8.2 Acute Migraine Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Abbott Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Acute Migraine Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Acute Migraine Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Acute Migraine Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Acute Migraine Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Acute Migraine Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Acute Migraine Drugs Market Analysis by Regions
4.1 Global Acute Migraine Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Acute Migraine Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Acute Migraine Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Acute Migraine Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Acute Migraine Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Acute Migraine Drugs Sales and Growth Rate (2014-2019)
4.5 South America Acute Migraine Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Acute Migraine Drugs Sales and Growth Rate (2014-2019)
5 North America Acute Migraine Drugs by Country
5.1 North America Acute Migraine Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Acute Migraine Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Acute Migraine Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Acute Migraine Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Acute Migraine Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Acute Migraine Drugs Sales and Growth Rate (2014-2019)
6 Europe Acute Migraine Drugs by Country
6.1 Europe Acute Migraine Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Acute Migraine Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Acute Migraine Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Acute Migraine Drugs Sales and Growth Rate (2014-2019)
6.3 UK Acute Migraine Drugs Sales and Growth Rate (2014-2019)
6.4 France Acute Migraine Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Acute Migraine Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Acute Migraine Drugs by Country
7.1 Asia-Pacific Acute Migraine Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Acute Migraine Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Acute Migraine Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Acute Migraine Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Acute Migraine Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Acute Migraine Drugs Sales and Growth Rate (2014-2019)
7.5 India Acute Migraine Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
8 South America Acute Migraine Drugs by Country
8.1 South America Acute Migraine Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Acute Migraine Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Acute Migraine Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Acute Migraine Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Acute Migraine Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Acute Migraine Drugs by Countries
9.1 Middle East and Africa Acute Migraine Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Acute Migraine Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Acute Migraine Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Acute Migraine Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Acute Migraine Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Acute Migraine Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Acute Migraine Drugs Sales and Growth Rate (2014-2019)
10 Global Acute Migraine Drugs Market Segment by Type
10.1 Global Acute Migraine Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Acute Migraine Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Acute Migraine Drugs Revenue and Market Share by Type (2014-2019)
10.2 Nonsteroidal Anti-Inflammatory Drugs Sales Growth and Price
10.2.1 Global Nonsteroidal Anti-Inflammatory Drugs Sales Growth (2014-2019)
10.2.2 Global Nonsteroidal Anti-Inflammatory Drugs Price (2014-2019)
10.3 Triptans Sales Growth and Price
10.3.1 Global Triptans Sales Growth (2014-2019)
10.3.2 Global Triptans Price (2014-2019)
10.4 Dihydroergotamine Sales Growth and Price
10.4.1 Global Dihydroergotamine Sales Growth (2014-2019)
10.4.2 Global Dihydroergotamine Price (2014-2019)
10.5 Nonspecific Migraine Medications Sales Growth and Price
10.5.1 Global Nonspecific Migraine Medications Sales Growth (2014-2019)
10.5.2 Global Nonspecific Migraine Medications Price (2014-2019)
10.6 Analgesics Sales Growth and Price
10.6.1 Global Analgesics Sales Growth (2014-2019)
10.6.2 Global Analgesics Price (2014-2019)
11 Global Acute Migraine Drugs Market Segment by Application
11.1 Global Acute Migraine Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Drug Stores Sales Growth (2014-2019)
11.4 Retail Pharmacies Sales Growth (2014-2019)
11.5 Online Pharmacies Sales Growth (2014-2019)
12 Acute Migraine Drugs Market Forecast (2019-2024)
12.1 Global Acute Migraine Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Acute Migraine Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Acute Migraine Drugs Market Forecast (2019-2024)
12.2.2 Europe Acute Migraine Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Acute Migraine Drugs Market Forecast (2019-2024)
12.2.4 South America Acute Migraine Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Acute Migraine Drugs Market Forecast (2019-2024)
12.3 Acute Migraine Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Acute Migraine Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Acute Migraine Drugs Market Share Forecast by Type (2019-2024)
12.4 Acute Migraine Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Acute Migraine Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Acute Migraine Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Acute Migraine Drugs Picture
Table Product Specifications of Acute Migraine Drugs
Figure Global Sales Market Share of Acute Migraine Drugs by Types in 2018
Table Acute Migraine Drugs Types for Major Manufacturers
Figure Nonsteroidal Anti-Inflammatory Drugs Picture
Figure Triptans Picture
Figure Dihydroergotamine Picture
Figure Nonspecific Migraine Medications Picture
Figure Analgesics Picture
Figure Acute Migraine Drugs Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Drug Stores Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Acute Migraine Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Acute Migraine Drugs Type and Applications
Table Amgen Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Acute Migraine Drugs Type and Applications
Table Pfizer Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Acute Migraine Drugs Type and Applications
Table Novartis Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lily Basic Information, Manufacturing Base and Competitors
Table Eli Lily Acute Migraine Drugs Type and Applications
Table Eli Lily Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Acute Migraine Drugs Type and Applications
Table AstraZeneca Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Acute Migraine Drugs Type and Applications
Table Teva Pharmaceutical Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Acute Migraine Drugs Type and Applications
Table Allergan Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Acute Migraine Drugs Type and Applications
Table Abbott Acute Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Acute Migraine Drugs Sales by Manufacturer (2017-2018)
Figure Global Acute Migraine Drugs Sales Market Share by Manufacturer in 2017
Figure Global Acute Migraine Drugs Sales Market Share by Manufacturer in 2018
Table Global Acute Migraine Drugs Revenue by Manufacturer (2017-2018)
Figure Global Acute Migraine Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Acute Migraine Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Acute Migraine Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Acute Migraine Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Global Acute Migraine Drugs Revenue and Growth Rate (2014-2019)
Table Global Acute Migraine Drugs Sales by Regions (2014-2019)
Table Global Acute Migraine Drugs Sales Market Share by Regions (2014-2019)
Table Global Acute Migraine Drugs Revenue by Regions (2014-2019)
Figure Global Acute Migraine Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Acute Migraine Drugs Revenue Market Share by Regions in 2018
Figure North America Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Europe Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure South America Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure North America Acute Migraine Drugs Revenue and Growth Rate (2014-2019)
Table North America Acute Migraine Drugs Sales by Countries (2014-2019)
Table North America Acute Migraine Drugs Sales Market Share by Countries (2014-2019)
Figure North America Acute Migraine Drugs Sales Market Share by Countries (2014-2019)
Figure North America Acute Migraine Drugs Sales Market Share by Countries in 2018
Table North America Acute Migraine Drugs Revenue by Countries (2014-2019)
Table North America Acute Migraine Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Acute Migraine Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Acute Migraine Drugs Revenue Market Share by Countries in 2018
Figure United States Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Canada Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Europe Acute Migraine Drugs Revenue and Growth Rate (2014-2019)
Table Europe Acute Migraine Drugs Sales by Countries (2014-2019)
Table Europe Acute Migraine Drugs Sales Market Share by Countries (2014-2019)
Table Europe Acute Migraine Drugs Revenue by Countries (2014-2019)
Figure Europe Acute Migraine Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Acute Migraine Drugs Revenue Market Share by Countries in 2018
Figure Germany Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure UK Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure France Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Russia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Italy Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Acute Migraine Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Acute Migraine Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Acute Migraine Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Acute Migraine Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Acute Migraine Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Acute Migraine Drugs Revenue Market Share by Countries 2018
Figure China Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Japan Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Korea Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure India Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure South America Acute Migraine Drugs Revenue and Growth Rate (2014-2019)
Table South America Acute Migraine Drugs Sales by Countries (2014-2019)
Table South America Acute Migraine Drugs Sales Market Share by Countries (2014-2019)
Figure South America Acute Migraine Drugs Sales Market Share by Countries in 2018
Table South America Acute Migraine Drugs Revenue by Countries (2014-2019)
Table South America Acute Migraine Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Acute Migraine Drugs Revenue Market Share by Countries in 2018
Figure Brazil Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Acute Migraine Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Acute Migraine Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Acute Migraine Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Acute Migraine Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Acute Migraine Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Acute Migraine Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Acute Migraine Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Acute Migraine Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure UAE Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Acute Migraine Drugs Sales and Growth Rate (2014-2019)
Table Global Acute Migraine Drugs Sales by Type (2014-2019)
Table Global Acute Migraine Drugs Sales Share by Type (2014-2019)
Table Global Acute Migraine Drugs Revenue by Type (2014-2019)
Table Global Acute Migraine Drugs Revenue Share by Type (2014-2019)
Figure Global Nonsteroidal Anti-Inflammatory Drugs Sales Growth (2014-2019)
Figure Global Nonsteroidal Anti-Inflammatory Drugs Price (2014-2019)
Figure Global Triptans Sales Growth (2014-2019)
Figure Global Triptans Price (2014-2019)
Figure Global Dihydroergotamine Sales Growth (2014-2019)
Figure Global Dihydroergotamine Price (2014-2019)
Figure Global Nonspecific Migraine Medications Sales Growth (2014-2019)
Figure Global Nonspecific Migraine Medications Price (2014-2019)
Figure Global Analgesics Sales Growth (2014-2019)
Figure Global Analgesics Price (2014-2019)
Table Global Acute Migraine Drugs Sales by Application (2014-2019)
Table Global Acute Migraine Drugs Sales Share by Application (2014-2019)
Figure Global Drug Stores Sales Growth (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Acute Migraine Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Acute Migraine Drugs Sales Forecast by Regions (2019-2024)
Table Global Acute Migraine Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Acute Migraine Drugs Market Forecast (2019-2024)
Figure Europe Sales Acute Migraine Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Acute Migraine Drugs Market Forecast (2019-2024)
Figure South America Sales Acute Migraine Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Acute Migraine Drugs Market Forecast (2019-2024)
Table Global Acute Migraine Drugs Sales Forecast by Type (2019-2024)
Table Global Acute Migraine Drugs Market Share Forecast by Type (2019-2024)
Table Global Acute Migraine Drugs Sales Forecast by Application (2019-2024)
Table Global Acute Migraine Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
急性片頭痛治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） A migraine is an episodic and unpredictable headache disorder that presents with disabling attacks. Treatment of a migraine attack should be guided by response to previous treatment and the severity of the attacks. Scope of the Report: The global Acute Migraine Treatments market is valued at xx mill…- 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の脳幹オーラ薬と片頭痛市場：市場規模・現状・予測 A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occu…
- 抗片頭痛薬市場：世界及び中国市場分析・予測（～2024年） Anti-Migraine Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anti-Migraine Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti-Migraine Drugs manufactur…
- 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …